Aden

Aden is a US-based precision health company founded in 2025 by Sarah Cronin. Its membership pairs at-home blood draws covering more than 125 biomarkers with personalised health protocols, and members retest every six months so the protocol updates as their biology changes. Launched in the UAE in October 2026, the company plans to add genetics, microbiome, body composition and VO2 max data over time and to expand to other GCC markets and global wellness hubs.

  • Seed
  • Biotechnology
  • Consumer Software
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Oct 12, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Oct 12, 2026

    $2M

    Seed

    Article coming soon.

Pricing

Research Aden — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Aden is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational